Current and emerging therapeutic options for the treatment of chronic chagasic cardiomyopathy

References

• World Health OrganizationControl of Chagas’ diseaseReport of a WHO Expert Committee. Technical Report Series 811, Geneva, 1991
   Google Scholar
• RosenbaumMBChagasic myocardiopathyProg Cardiovasc Dis1964719922514223289
   PubMed Web of Science ®Google Scholar
• El-SayedNMMylerPJBartholomeuDCThe genome sequence of Trypanosoma cruzi, etiologic agent of Chagas diseaseScience2005309573340941516020725
   PubMed Web of Science ®Google Scholar
• NunesMCBarbosaMMRibeiroALBarbosaFBRochaMOIschemic cerebrovascular events in patients with Chagas cardiomyopathy: a prospective follow-up studyJ Neurol Sci20092781–29610119162278
   PubMed Web of Science ®Google Scholar
• DiasELaranjaFSMirandaANobregaGChagas’ disease: a clinical, epidemiologic and pathologic studyCirculation1956141035106013383798
   PubMed Web of Science ®Google Scholar
• MotaEAGuimaraesACSantanaOOSherlockIHoffRWellerTHA nine year prospective study of Chagas’ disease in a defined rural population in northeast BrazilAm J Trop Med Hyg1990424294402111098
   PubMed Web of Science ®Google Scholar
• ArasRde MattaJAMotaGGomesIMeloACerebral infarction in autopsies of chagasic patients with heart failureArq Bras Cardiol20038411413
   Google Scholar
• RassiAJrRassiSGRassiASudden death in Chagas’ diseaseArq Bras Cardiol200176759611175486
   PubMedGoogle Scholar
• BaranchukARosasFMorilloCAEnfermedad de Chagas en Países Desarrollados: Mito o Realidad (Chagas’ disease in developed countries: myth or reality)RosasFVanegasDCabralesMEnfermedad de Chagas, Bogotá, Sociedad Colombiana de Cardiología, Sociedad Española de Cardiología2007217219
   Google Scholar
• RobertiRRMartinezEEAndradeJLChagas cardiomyopathy and captoprilEur Heart J1992139669701644089
   PubMed Web of Science ®Google Scholar
• SzajnbokFEBarrettoACMadyCBeneficial effects of enalapril on the diastolic ventricular function in Chagas myocardiopathyArq Bras Cardiol1993602732788311739
   PubMedGoogle Scholar
• DavilaDFAngelFArataDBEffects of metoprolol in chagasic patients with severe congestive heart failureInt J Cardiol20028525526012208592
   PubMed Web of Science ®Google Scholar
• BotoniFAPoole-WilsonPARibeiroALA randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas cardiomyopathyAm Heart J200715354454817383291
   PubMed Web of Science ®Google Scholar
• IssaVSAmaralAFCruzFDBeta-blocker therapy and mortality of patients with Chagas cardiomyopathy: a subanalysis of the REMADHE prospective trialCirc Heart Fail20103828819933408
   PubMed Web of Science ®Google Scholar
• LaranjaFSDiasENobregaGMirandaAChagas’ disease. A clinical, epidemiologic and pathologic studyCirculation1956141035106013383798
   PubMed Web of Science ®Google Scholar
• AndradeZAAndradeSGOliveiraGAlonsoDRHistopathology of the conduction tissue of the heart in Chagas’ myocarditisAm Heart J197893316324414610
   PubMedGoogle Scholar
• ElizariMVChialePACardiac Arrhythmias in Chagas’ heart diseaseJ Cardiovasc Electrophysiol199345965988269325
   PubMed Web of Science ®Google Scholar
• MadoeryCRuizAMartinez RubioAMadoeryRSignal-averaged electrocardiography in Chagas’ diseaseTentoriMCSeguraLHayesDLArrhythmia management in chagas’ diseaseNew YorkFutura Publishing Co. Inc20006782
   Google Scholar
• RabinovichRMuratoreCBaranchukAModo de inicio de las taquiarritmias ventriculares en la cardiopatía chagásica crónicaArch Cardiol Mex2008783248253
   Google Scholar
• BaruffaGContribuicao ao conhecimento da forma cronica da doenca de Chagas na zona sul do Rio Grande do SulR AMRIGS197418237250
   Google Scholar
• AquatellaHCataliotiFGomez-ManceboJRLong-term control of Chagas disease in Venezuela: effects on serologic findings, electrocardiographic abnormalities, and clinical outcomeCirculation1987765565622957109
   PubMed Web of Science ®Google Scholar
• GarzonSACLorgaAMJacobJLBPredictors of mortality in chronic Chagas heart disease long-term follow up of 987 subjects for up to 22 yearsJ Am Coll Cardiol199831107C
   Google Scholar
• RassiAJrWaktareJEPRassiSGChagas heart disease: long term prognostic significance of nonsustained ventricular tachycardia and lef ventricular dysfunctionPACE199922862
   Google Scholar
• CouraJRAbreuLLPereiraJBWillcoxHPMorbidade da doença de Chagas. IV Estudo longitudinal de dez anos em Pains e Iguatama, Minas Gerais, BrasilMem Inst Oswaldo Cruz19858073803937015
   PubMedGoogle Scholar
• CarrascoHAParadaHGuerreroLDuqueMDuranDMolinaCPrognostic implications of clinical, electrocardiographic and hemodynamic findings in chronic Chagas’ diseaseInt J Cardiol19944327388175216
   PubMed Web of Science ®Google Scholar
• De PaolaAAGomesJATerzianABMyamotoMHMartinez FilhoEVentricular tachycardia during exercise testing as a predictor of sudden death in patients with chronic chagasic cardiomyopathy and ventricular arrhythmiasBr Heart J1995742932957547025
   PubMedGoogle Scholar
• HaedoAHChialePABandieriJDLazzariJOElizariMVRosenbaumMBComparative antiarrhythmic efficacy of verapamil, 17-monochloracetylajmaline, mexiletine and amiodarone in patients with severe chagasic myocarditis: relation with the underlying arrhythmogenic mechanismsJ Am Coll Cardiol19867111411203958370
   PubMedGoogle Scholar
• RosenbaumMPosseRSgamminiHComparative multicenter clinical study of flecainide and amiodarone in the treatment of ventricular arrhythmias associated with chronic Chagas cardiopathyArch Inst Cardiol Mex198757325330
   Google Scholar
• ChialePAHalpernMSNauGJEfficacy of amiodarone during long-term treatment of malignant ventricular arrhythmias in patients with chronic chagasic myocarditisAm Heart J19841076566656702559
   PubMedGoogle Scholar
• ScanavaccaMISosaEALeeJHBellottiGPileggiFEmpiric therapy with amiodarone in patients with chronic Chagas cardiomyopathy and sustained ventricular tachycardiaArq Bras Cardiol1990543673712288524
   PubMedGoogle Scholar
• BarbosaECAlbanesi FilhoFMGinefraPEvaluation of syncope in patients with chronic Chagas heart diseaseArq Bras Cardiol1991573013051824525
   PubMedGoogle Scholar
• SarabandaAVSosaESimõesMVFigueiredoGLPintyaAOMarin-NetoJAVentricular tachycardia in Chagas’ disease: a comparison of clinical, angiographic, electrophysiologic and myocardial perfusion disturbances between patients presenting with either sustained or nonsustained formsInt J Cardiol2005102191915939094
   PubMed Web of Science ®Google Scholar
• LeiteLFenelonGSimoesAJrClinical usefulness of electrophysiologic testing in patients with ventricular tachycardia and chronic chagasic cardiomyopathy treated with amiodarone and sotalolJ Cardiovasc Electrophysiol20031456757312875414
   PubMed Web of Science ®Google Scholar
• The Antiarrhythmics Versus Implantable Defibrillator (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmiasN Engl J Med1997337157615839411221
   PubMed Web of Science ®Google Scholar
• ConnollySJGentMRobertsRSCanadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodaroneCirculation20001011297130210725290
   PubMed Web of Science ®Google Scholar
• KuckKHCappatoRSiebelsJRuppelRRandomized comparison of antiarrhythmia drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH)Circulation200010274875410942742
   PubMed Web of Science ®Google Scholar
• MossAJZarebaWHallWJProphylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fractionN Engl Med J2002346877883
   PubMed Web of Science ®Google Scholar
• BardyGHLeeKLMarkDBAmiodarone or an implantable cardioverter Amiodarone or an implantable cardioverter-defibrillator for congestive heart failureN Engl J Med200535222523715659722
   PubMed Web of Science ®Google Scholar
• MuratoreCRabinovichRIglesiasRGonzalezMDarúVSosa LiprandiAImplantable cardioverter defibrillators in patients with chagas disease: are they different from patients with coronary diseasePACE1997201941979121988
   PubMedGoogle Scholar
• Cardinalli-NetoAGrecoOBestettiRAutomatic implantable cardioverter-defibrillators in chagas heart disease patients with malignant ventricular arrhythmiasPACE20062946747016689840
   PubMedGoogle Scholar
• Cardinalli-NetoABestettiRCordeiroJRodriguesVPredictors of all-cause mortality for patients with chronic chagas heart disease receiving implantable cardioverter defibrillator therapyJ Cardiovasc Electrophysiol2007181236124017900257
   PubMed Web of Science ®Google Scholar
• MuratoreCBatista SaLChialePImplantable cardioverter defibrillators and Chagas’ disease: results of the ICD Registry Latin AmericaEuropace200911216416819056745
   PubMedGoogle Scholar
• Di ToroDMuratoreCAguinagaLPredictors of all-cause 1 year mortality for patients with chronic chagas’ heart disease receiving implantable cardioverter defibrillator therapy in the ICD registry. (Abstract). Accepted for presentation Heart Rhythm Society 2010
   Google Scholar
• RabinovichRMuratoreCIglesiasRTime to first shock in implantable cardioverter defibrillator (ICD) patients with Chagas cardiomyopathyPacing Clin Electrophysiol1999222022059990631
   PubMedGoogle Scholar
• GrecoOTArditoRVGarzonSAFollow-up of 991 patients with multiprogrammable artificial cardiac pacemakerArq Bras Cardiol1987493273313454156
   PubMedGoogle Scholar
• Vanegas CadavidDIMarcapassos na doença de chagasRev Latino Americana MCP y Arritmias2008217076
   Google Scholar
• TentoriCChirifeRRuizAMazzettiHStygliczEMenendezCLong-term evaluation of patients with chronic Chagas disease and implanted cardiac pacemaker. (Abstract). Accepted for presentation Cardiostim 2010 (in press).
   Google Scholar
• Garcia RinconLCosta RochaMBaccarini PirisMPerfil clínico de pacientes chagásicos e não-chagásicos portadores de marca-passo cardíaco artificialRev Soc Bras Med Trop200639324524916906246
   PubMedGoogle Scholar
• CostaRRassiALeaoMEstudo clínico e epidemiológico de pacientes submetidos a implante de marcapasso cardíaco artificial permanente: comparação dos portadores da doença de Chagas com os de doenças degenerativas do sistema de conduçãoRev Bras Cir Cardiovasc2004192107114
   Google Scholar
• d’AvilaASplinterRSvensonRHChagas’ disease: experimental evidence of the efficacy of near infrared lasers for catheter ablation of Chagas’ VTJ Interv Card Electrophysiol200271233812391418
   PubMedGoogle Scholar
• RosasFVelascoVArboledaFCatheter ablation of ventricular tachycardia in Chagasic cardiomyopathyClin Cardiol19972021691749034647
   PubMedGoogle Scholar
• SosaEScanavaccaMD’AvilaABellottiGPilleggiFRadiofrequency catheter ablation of ventricular tachycardia guided by nonsurgical epicardial mapping in chronic Chagasic heart diseasePacing Clin Electrophysiol1999221281309990612
   PubMedGoogle Scholar
• HenzBDdo NascimentoTADietrichCSimultaneous epicardial and endocardial substrate mapping and radiofrequency catheter ablation as first-line treatment for ventricular tachycardia and frequent ICD shocks in chronic chagasic cardiomyopathyJ Interv Card Electrophysiol200926319520519757003
   PubMedGoogle Scholar
• ScanavaccaMSosaEd’AvilaADe Lourdes HiguchiMRadiofrequency ablation of sustained ventricular tachycardia related to the mitral isthmus in Chagas’ diseasePacing Clin Electrophysiol200225336837111990669
   PubMedGoogle Scholar
• ReddyVYReynoldsMRNeuzilPProphylactic catheter ablation for the prevention of defibrillator therapyN Engl J Med20073572657266518160685
   PubMed Web of Science ®Google Scholar
• St John SuttonMGPlappertTAbrahamWTEffect of cardiac resynchronization on left ventricular size and function in chronic heart failureCirculation20031071985199012668512
   PubMed Web of Science ®Google Scholar
• AbrahamWTYoungJBLeónAREffects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failureCirculation20041102864286815505095
   PubMed Web of Science ®Google Scholar
• BristowMRSaxonLABoehmerJCardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failureN Engl J Med20043502140215015152059
   PubMed Web of Science ®Google Scholar
• ClelandJGFDaubertJCErdmannEThe effect of cardiac resynchronization on morbidity and mortality in heart failureN Engl J Med20053521539154915753115
   PubMed Web of Science ®Google Scholar
• EpsteinADiMarcoJEllenbogenKACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinesCirculation2008117e350e40818483207
   PubMed Web of Science ®Google Scholar
• UpadhyayGChoudhryNAuricchioACardiac resynchronization in patients with atrial fibrillationJ Am Coll Cardiol2008521239124618926327
   PubMed Web of Science ®Google Scholar
• Alves FagundesALatado BragaAPereira MagalhaesLImpacto da terapia de ressincronizacao cardíaca na cardiopatía chagásicaRev Latino Americana MCP y Arritmias2009224243
   Google Scholar
• Vilas-BoasFFeitosaGSSoaresMBEarly results of bone marrow cell transplantation to the myocardium of patients with heart failure due to Chagas diseaseArq Bras Cardiol20068715916616951834
   PubMedGoogle Scholar
• TraininiJCBarisaniJLLagoNResultados alejados del implante miocárdico de células madre en la miocardiopatía chagásica RevArgent Cardiol200775257263
   Google Scholar
• Clinical Trials. Cell therapy in Changes cardiomyopathy. 2010. Available from: http://www.clinicaltrials.gov/ct2/show/NCT00349271 Accessed on May 1, 2010.
   Google Scholar
• CaldasISTalvaniACaldasSBenznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesionsParasitol Res2008103241342118454349
   PubMed Web of Science ®Google Scholar
• Marin-NetoJACunha-NetoEMacielBCSimoesMVPathogenesis of chronic chagas heart diseaseCirculation20071151109112317339569
   PubMed Web of Science ®Google Scholar
• GarciaSRamosCOSenraJFVTreatment with benznidazole during the chronic phase of experimental chagas’ disease decreases cardiac alterationsAntimicrob Agents and Chemother2005491521152815793134
   PubMed Web of Science ®Google Scholar
• Marin-NetoJARassiAJrMorilloCABENEFIT InvestigatorsRationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas’ cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT)Am Heart J20081561374318585495
   PubMed Web of Science ®Google Scholar
• Personal communication (Dr. Carlos A. Morillo), Jan 9th, 2010.
   Google Scholar
• AaronsonKDSchwartzJSChenTMDevelopment and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluationCirculation199795266026679193435
   PubMed Web of Science ®Google Scholar
• MehraNRKobashigawaJStarlingRListing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates 2006J Heart Lung Transplant2006251024104216962464
   PubMed Web of Science ®Google Scholar
• FranciosaJAWilenMZiescheSCohnJNSurvival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathyAm J Cardiol1983518318366681931
   PubMed Web of Science ®Google Scholar
• WilsonJRSchwartzJSSt John SuttonMPrognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activityJ Am Coll Cardiol198324034106192158
   PubMed Web of Science ®Google Scholar
• FusterVGershBJGiulianiERTajikAJBrandenburgROFryeRLThe natural history of idiopathic dilated cardiomyopathyAm J Cardiol1981475255317468489
   PubMed Web of Science ®Google Scholar
• BertolinoNDVillafanhaDFCardinalli-NetoAPrognostic impact of Chagas’ disease in patients awaiting heart transplantationJ Heart Lung Transplant201029444945320006935
   PubMedGoogle Scholar
• MadyCCardosoRHBarretoACSurvival and predictors of survival in patients with congestive heart failure due to Chagas’ cardiomyopathyCirculation199490309831027994859
   PubMed Web of Science ®Google Scholar
• DibJABestettiRBFreitasPFPredictors of all-cause mortality for patients with Chagas’ cardiomyopathy listed for heart transplantationInt J Cardiol2009136216216418649959
   PubMed Web of Science ®Google Scholar
• BocchiEAFiorelliAThe paradox of survival results after heart transplantation for cardiomyopathy caused by Trypanosoma cruziAnn Thorac Surg2001711833183811426756
   PubMed Web of Science ®Google Scholar
• CamposSVStrabelliTMAmato NetoVRisk factors for Chagas’ disease reactivation after heart transplantationJ Heart Lung Transplant200827659760218503957
   PubMed Web of Science ®Google Scholar
• GodoyHLGuerraCMViegasRFInfections in heart transplant recipients in Brazil: the challenge of Chagas’ diseaseJ Heart Lung Transplant201029328629019783174
   PubMedGoogle Scholar
• BocchiEABellottiGMocelinAHeart transplantation for chronic Chagas’ heart diseaseAnn Thorac Surg199661172717338651775
   PubMedGoogle Scholar
• CarvalhoVBSouzaEFLVilaJHATransplantation in Chagas’ disease: 10 years after the initial experienceCirculation199694181518178873654
   PubMedGoogle Scholar
• AlmeidaDRCarvalhoACCBrancoJNChagas disease reactivation after heart transplantation: efficacy of allopurinol treatmentJ Heart Lung Transplant1996159889928913915
   PubMedGoogle Scholar